Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Net Income (2016 - 2024)

Historic Net Income for Arcadia Biosciences (RKDA) over the last 11 years, with Q4 2024 value amounting to -$27000.0.

  • Arcadia Biosciences' Net Income rose 9875.63% to -$27000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$27000.0, marking a year-over-year increase of 9944.51%. This contributed to the annual value of -$2.7 million for FY2024, which is 6527.57% up from last year.
  • As of Q4 2024, Arcadia Biosciences' Net Income stood at -$27000.0, which was up 9875.63% from -$430000.0 recorded in Q3 2024.
  • In the past 5 years, Arcadia Biosciences' Net Income ranged from a high of $7.6 million in Q4 2020 and a low of -$13.8 million during Q4 2021
  • For the 5-year period, Arcadia Biosciences' Net Income averaged around -$3.5 million, with its median value being -$2.1 million (2023).
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 22027.56% in 2020, then crashed by 71546.96% in 2024.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Net Income stood at $7.6 million in 2020, then plummeted by 281.77% to -$13.8 million in 2021, then surged by 91.68% to -$1.1 million in 2022, then crashed by 89.11% to -$2.2 million in 2023, then soared by 98.76% to -$27000.0 in 2024.
  • Its Net Income was -$27000.0 in Q4 2024, compared to -$430000.0 in Q3 2024 and -$789000.0 in Q2 2024.